Baptist Health System/Mid South NCORP Minority Underserved Consortium

描述（由申请人提供）：浸信会社区卫生保健公司（BMHCC）的浸信会癌症中心（BCC）代表浸信会卫生系统/中南NCORP少数民族/服务不足的财团申请成为NCI社区肿瘤学研究计划（NCORP）的少数民族/服务不足的社区网站。该联盟将BCC/BMHCC在孟菲斯市区和周边农村市场的大型综合癌症护理提供计划与城市Meharry医学院（MCC）计划结合起来，该计划具有少数民族社区临床肿瘤学计划（MB-CCOP）的经验，以及Vanderbilt-Ingram癌症中心（VICC）的支持和合作，VICC是BCC和MMC在转化临床试验中的联合合作伙伴，癌症治疗和人口研究。联合集水区的人口超过40%是非洲裔美国人，5%是其他少数民族，约25%是农村人口，是全国最贫穷的人口之一。总的来说，该联盟每年治疗5,000多例新的癌症病例。NCORP的投资将支持加强临床试验系统，为少数民族和农村人口服务的实践中的试验教育和招生外展，并与社区初级保健中心合作进行相关的治疗和筛查，预防和其他试验，以及在这些社区进行癌症护理研究。该联盟的提案建立在BMHCC和MMC现有的广泛临床试验和数据管理基础设施之上。这两个团体都在其集水区服务不足的地区开展社区外展和合作初级保健项目。BMHCC还拥有出色的癌症护理提供研究（CCDR）基础设施，包括信息技术支持，可访问BMHCC全系统的管理和患者数据，以及在所有医院，门诊设施和医生办公室新安装的全系统电子健康记录（EPIC）。BMHCC也有正在进行的NCI和PCORI资助的CCDR。联盟领导人在临床试验、MB-CCOP、癌症数据管理和CCDR方面拥有丰富的经验。该联盟将成为所有领域临床试验的强大贡献者，并为NCORP癌症护理差异研究议程的发展做出强有力的贡献。

DESCRIPTION (provided by applicant): The Baptist Community Health Care Corporation (BMHCC)'s Baptist Cancer Center (BCC) is applying on behalf of the Baptist Health System/Mid-South NCORP Minority/Underserved Consortium to become a Minority/Underserved Community Site for the NCI Community Oncology Research Program (NCORP). The Consortium brings the BCC/BMHCC's large integrated cancer care delivery program in the urban area of Memphis and surrounding rural markets with the urban Meharry Medical College (MCC) program with its experience as a Minority-Based Community Clinical Oncology Program (MB-CCOP), and the support and collaboration of the Vanderbilt-lngram Cancer Center (VICC), a joint partner of BCC and MMC in translational clinical trials, cancer care delivery, and population research. The joint catchment area's population is over 40% African American, 5% other minority groups, about 25% rural, and among the poorest in the nation. Overall, the Consortium practices treat over 5,000 new cancer cases annually. The NCORP investment will support enhancement of the clinical trials system, outreach for trial education and enrollment in practices serving minority and rural populations, and collaboration with community primary care centers for relevant treatment and screening, prevention and other trials, and in cancer care delivery research in these communities. The Consortium's proposal is built on an existing extensive clinical trial and data management infrastructure at BMHCC and MMC. Both groups have community outreach and collaborative primary care programs in underserved parts of their catchment areas. BMHCC also has an excellent infrastructure for cancer care delivery research (CCDR) including information technology support with access to BMHCC system-wide administrative and patient data, plus a newly installed system-wide electronic health record (EPIC) in all hospitals, ambulatory facilities and physician offices. BMHCC also has ongoing NCI and PCORI-funded CCDR. The Consortium leaders have broad experience in clinical trials, MB-CCOPs, cancer data management and CCDR. The Consortium will be a strong contributor to clinical trials in all areas, and a strong contributor to the development of the NCORP research agenda in cancer care disparities.